Suppr超能文献

COVID-19 大流行相关封锁期间微生物性角膜炎管理面临的挑战:与大流行前数据的对比分析。

Challenges in management of microbial keratitis during COVID-19 pandemic related lockdown: a comparative analysis with pre pandemic data.

机构信息

The Cornea Institute, KVC Campus, Vijayawada, India.

The Cornea Institute, GMRV Campus, Vishakhapatnam, India.

出版信息

Int Ophthalmol. 2023 May;43(5):1639-1645. doi: 10.1007/s10792-022-02562-5. Epub 2022 Oct 22.

Abstract

PURPOSE

To study the challenges of managing microbial keratitis(MK) during the COVID19 pandemic related lockdown and assess the outcomes of treatment at a tertiary cornea service.

METHODS

Retrospective, non comparative study of electronic medical records of MK presenting to a network of four tertiary care cornea services. The medical history, presenting clinical features, microbiology work up and treatment outcomes were analyzed. The primary outcome measure was final outcome at last follow up. Secondary outcomes measures were non-compliance to treatment due to travel restrictions, therapeutic PKP not done due non availability of corneal tissues. Results- MK was noted in 330 eyes of 330 patients between April and May 2020. Of these 237(71.8%) were males. Median age was 45 years(IQR, 33-56). Low socioeconomic status noted in 102(30.9%). Patients travelling beyond the district from where the hospital was located comprised of 64.9%(n=214). At a median follow up of 32 days(IQR, 9-54), 118(35.8%) patients had resolved, with medical management, 73(22.1%) patients were under active treatment, 139(42.1%) were lost to follow up. Sixty-six patients(20%) were non-compliant to treatment of which 59 could not follow appointment schedule due to travel restrictions. Therapeutic PKP (TPK) was planned in 48/128 (37.5%) patients, but was performed in only 34/48 (70.8%) due to non-availability of donor corneas.

CONCLUSIONS

Abnormal social circumstances due to the COVID pandemic and the ensuing impediments to travel for access to health care affected compliance to treatment of ocular emergencies such as microbial keratitis.

摘要

目的

研究 COVID19 大流行封锁期间管理微生物角膜炎(MK)的挑战,并评估三级角膜服务中的治疗结果。

方法

对四家三级护理角膜服务网络中出现的 MK 电子病历进行回顾性、非对照研究。分析了病史、临床表现、微生物学检查和治疗结果。主要结局指标为最后随访时的最终结局。次要结局指标为因旅行限制而无法遵医嘱治疗、因角膜组织无法获得而无法进行治疗性穿透性角膜移植术(PKP)。

结果

2020 年 4 月至 5 月,MK 见于 330 例 330 只眼中。其中 237 例(71.8%)为男性。中位年龄为 45 岁(IQR,33-56)。102 例(30.9%)社会经济地位较低。从医院所在地所在县以外地区来就诊的患者占 64.9%(n=214)。中位随访 32 天(IQR,9-54),118 例(35.8%)患者经药物治疗后痊愈,73 例(22.1%)患者正在积极治疗中,139 例(42.1%)失访。66 例(20%)患者不遵医嘱治疗,其中 59 例因旅行限制无法按预约时间就诊。计划对 48/128(37.5%)例患者进行治疗性 PKP,但由于供体角膜缺乏,仅对 34/48(70.8%)例患者进行了治疗。

结论

COVID 大流行导致的社会环境异常以及随之而来的就医旅行障碍,影响了眼部急症(如微生物角膜炎)的治疗依从性。

相似文献

引用本文的文献

5
Considerations of COVID-19 in Ophthalmology.眼科领域中对新型冠状病毒肺炎的考量
Microorganisms. 2023 Aug 31;11(9):2220. doi: 10.3390/microorganisms11092220.

本文引用的文献

5
Tele-ophthalmology: Need of the hour.远程眼科学:当下的需求。
Indian J Ophthalmol. 2020 Jul;68(7):1328-1338. doi: 10.4103/ijo.IJO_1784_20.
6
COVID-19 and eye banking.新型冠状病毒肺炎与眼库
Indian J Ophthalmol. 2020 Jun;68(6):1215-1216. doi: 10.4103/ijo.IJO_1033_20.
8
India under COVID-19 lockdown.处于新冠疫情封锁下的印度。
Lancet. 2020 Apr 25;395(10233):1315. doi: 10.1016/S0140-6736(20)30938-7.
9
COVID-19 pandemic: Lessons learned and future directions.COVID-19 大流行:经验教训和未来方向。
Indian J Ophthalmol. 2020 May;68(5):703-710. doi: 10.4103/ijo.IJO_843_20.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验